The Journal of
Clinical Psychiatry

Special Section

Focus on Women’s Mental Health

The objective of the Focus on Women’s Mental Health section is to recognize and address the need for gender-based research. Authors are invited to submit well-designed, well-conducted studies of epidemiologic, biological, psychosocial, economic, and health services aspects of women’s mental health issues. Topics of interest include all aspects of mental health issues pertinent to the female reproductive lifespan, disorders that disproportionately affect women, and inquiries into how gender impacts the course and treatment of disorders that affect the sexes equally.

Section Editor

Marlene P. Freeman, MD

Contact Dr Freeman

Learn more about Dr Freeman

Submit a Paper

for consideration in the Focus on Women’s Mental Health section

Learn How to Submit

JCP
Original Research

March 5, 2025

Risks of a postpartum suicide attempt were increased 4- to 30-fold by clinical factors, including prenatal suicide attempt ED visits, psychiatric ED visits, and assault ED visits, and by…
, , , et al
news

March 3, 2025

The SUMMIT trial found that non-specialists and telemedicine can effectively expand access to maternal mental health care.
JCP
Original Research

November 20, 2024

No significant difference was observed in the rate of postpartum MDD in Black (40%) versus white (35%) women. However, bipolar disorder significantly differed between Black (19.2%) and white (11.5%)…
, , , et al
JCP
Original Research

November 4, 2024

Individuals with a history of concussion had an increased risk of severe maternal mental illness; the association was strongest in those with no history of mental illness.
, , , et al
JCP
Original Research

August 26, 2024

Risks of fetal ketamine exposure are often overlooked, indicating a need for awareness about reproductive concerns when prescribing ketamine for psychiatric disorders.
, , , et al
JCP
Original Research

August 14, 2024

Although intrusive thoughts of accidental and intentional infant harm are a common and normative postpartum experience, they cause distress for many new mothers. Clinically significant symptoms that remain by…
, , , et al
JCP
Original Research

June 10, 2024

In patients of childbearing age who have had atypical responses or side effects to antidepressants, pharmacogenomic testing may be considered to guide dose or choice of agent. Dose adjustments…
, , , et al
JCP
Original Research

June 5, 2024

Women Veterans with PTSD were 67% more likely to initiate a guideline discordant medication. More than half of this effect was explained by bipolar disorder, age, and prior psychiatric…
, , , et al
JCP
Original Research

July 24, 2023

The increase in postpartum depression during the pandemic highlights a need for accessible interventions. In this study, online group CBT significantly reduced depression, worry, and rejection and pathological anger…
, , , et al
JCP
Commentary

July 24, 2023

Rachel Vanderkruik, PhD, MSc, discusses Huh and colleagues’ study of online nurse-delivered group CBT for postpartum depression, highlighting 4 key aspects that make the intervention particularly exciting.
JCP
Original Research

July 10, 2023

Hypertensive disorders of pregnancy (HDP) are a major complication. In this study, the risk of HDP with SNRIs (9.5%) was significantly higher than with SSRIs (5.5%).
, , , et al
JCP
Brief Report

May 15, 2023

This meta-analysis found that use of methylphenidate in the first trimester may be a risk factor for fetal congenital heart defects.
, , , et al

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe
pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy